Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-13

Clinical Trial Update: Mirabegron and Urinary Urgency Incontinence [Phase 4]

View source ↗

Summary

Phase 4 trial update on mirabegron for urinary urgency incontinence due to overactive bladder; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mirabegron (mirabegron)

Snippet

Sponsor: Loyola University | Conditions: Overactive Bladder | Phase 4 | Status: COMPLETED | Results posted: 2020-11-13